Could a simple bladder wash cut UTIs after catheter removal?
NCT ID NCT07239219
First seen Jun 26, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This study tests whether rinsing the bladder with Irrisept (a chlorhexidine solution) before removing a urinary catheter can prevent infections better than rinsing with salt water. Researchers will compare infection rates and antibiotic use in 300 adults. The goal is to find a non-antibiotic way to reduce UTIs and improve patient outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- 0.05% Chlorhexidine Gluconate (Irrisept)
- What this could lead to
- If it works, this could offer a simple, non-antibiotic way to prevent urinary tract infections after catheter removal, reducing the need for antibiotics.
- What could go wrong
- This is an early-stage study with no phase designation, so results are uncertain. The intervention may not reduce infections more than saline, and some people may have allergic reactions to chlorhexidine.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Jan 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Presenting to the urology clinic for catheter removal 2. Must be 18 years or older. 3. The patient must be able to understand and willing to provide informed consent as described in this study protocol. 4. Must be willing to complete a post-catheter removal survey Exclusion Criteria: 1. Allergy or adverse reaction to chlorohexidine gluconate 2. Under the age of 18 3. Refuse to provide informed consent 4. On antibiotic therapy for any indication. 5. Women who are pregnant or breastfeeding 6. Signs of skin or systemic infection 7. Patients undergoing catheter exchange
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Antibiotic are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
The Ohio State University
RECRUITINGColumbus, Ohio, 43212-3153, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- What lurks in urine? a biobank aims to decode Catheter-Related infections
- Can an ancient herbal formula beat antibiotics for urinary infections?
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Home hospital care for infections: when does it fail?
- New bandage for IVs could slash infection risk
- New trial aims to slash deadly bloodstream infections from hospital tubes